Skip to content

Clinical trials

Completed Hemolysis trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hemolysis Status: Completed Country / region: United States Clear all

20 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20021
20032
20051
20071
20081
20092
20113
20121
20151
20181
20191
20202
20221

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed20

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)4
National Heart, Lung, and Blood Institute (NHLBI)3
Alexion Pharmaceuticals, Inc.2
University of Mississippi, Oxford2
Apellis Pharmaceuticals, Inc.1
Emory University1
Forma Therapeutics, Inc.1
Montefiore Medical Center1
National Institutes of Health Clinical Center (CC)1
St. Jude Children's Research Hospital1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hemolysis20
Anemia, Hemolytic5
Anemia4
Anemia, Sickle Cell4
Hemoglobinuria, Paroxysmal4
Hepatitis C4
Fibrosis3
Glucosephosphate Dehydrogenase Deficiency3
Hematologic Diseases3
Hepatitis C, Chronic3

Trials

Showing 1 to 20 of 20. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.